Ever since our research group became involved in the development of new antioxidant drugs as a useful weapon against neurological diseases such as Alzheimer's and Parkinson's, it has focused on the development of antioxidant compounds. In recent years, we have designed and studied new polyazamacrocyclic compounds capable of mimicking superoxide dismutase and other enzymes involved in molecular oxygen metabolism.
